Glucagon-Like Peptide-1 Receptor Agonist Treatment and Risk of Esophageal Cancer
Year: 2025
Type: article
Language: en
Topic: Diabetes Treatment and Management
Authors and affiliations:
raw_author_name: Johan Hardvik Åkerström
raw_affiliation_strings: Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden
raw_author_name: Giola Santoni
raw_affiliation_strings: Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden
raw_author_name: My von Euler-Chelpin
raw_affiliation_strings: Department of Public Health, University of Copenhagen, Copenhagen, Denmark;
Department of Public Health, University of Copenhagen, Denmark
raw_author_name: Helgi Birgisson
raw_affiliation_strings: The Icelandic Cancer Registry, Reykjavik, Iceland;
The Icelandic Cancer Registry, Reykjavik, Iceland
raw_author_name: Eivind Ness-Jensen
raw_affiliation_strings: Department of Public Health and Nursing, HUNT Research Centre, NTNU, Norwegian University of Science and Technology, Trondheim/Levanger, Norway;
Medical Department, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway;
Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden
Medical Department, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway
HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim/Levanger, Norway
raw_author_name: Joonas H. Kauppila
raw_affiliation_strings: Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland;
Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden
Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland
raw_author_name: Dag Holmberg
raw_affiliation_strings: Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden
raw_author_name: Jesper Lagergren
raw_affiliation_strings: School of Cancer and Pharmaceutical Sciences, King's College London, London, UK
Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden
School of Cancer and Pharmaceutical Sciences, King's College London, United Kingdom